Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:02:27.958Z.
Calculation as of: 2026-10-06T18:02:27.958Z.
Quote observation: 2026-10-06T18:00:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a63c12ce7055b0216585e16b4e08b2fd6453147ab6d4be874ec80e726ee32667
EARNINGS YIELD
N/A
Market Cap
$132.66M
Earnings Yield
N/A
TTM Avg
0.52%
3Y Avg
2.38%
5Y Avg
2.38%
Market Cap
$134.99M
Earnings Yield
46.43%
TTM Avg
20.01%
3Y Avg
13.20%
5Y Avg
13.20%
Market Cap
$137.11M
Earnings Yield
N/A
TTM Avg
0.17%
3Y Avg
1.25%
5Y Avg
2.17%
Market Cap
$127.29M
Earnings Yield
N/A
TTM Avg
0.12%
3Y Avg
0.11%
5Y Avg
0.11%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $132.64M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.66M | N/A | 0.52% | 2.38% | 2.38% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | N/A | 5.34% | 5.34% | 5.34% |
| Organigram Global Inc. (OGI)vs › | $134.99M | 46.43% | 20.01% | 13.20% | 13.20% |
| Freenome, Inc. (FRNM)vs › | $135.33M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $129.56M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.66M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | N/A | 0.17% | 1.25% | 2.17% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | 0.12% | 0.11% | 0.11% |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | N/A | 60.17% | 53.61% | 53.61% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
